The aim of this study was to elucidate the usefulness of measuring the fucosylation index (FI) of ␣-fetoprotein (AFP) before the initiation of therapy as a new prognostic indicator for patients with hepatocellular carcinoma (HCC). ## METHODS. One hundred twelve patients with HCC who underwent tran
The use of a monoclonal antibody against α-fetoprotein for the radioimmunodetection of hepatocellular carcinoma
✍ Scribed by Elsa Springolo; Professor Michael C. Kew; Jan Esser; Margaretha Beyers; Jan D. Conradie; Joseph Levin
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 641 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## MASAO OMATA~ We attempted to detect circulating hepatocellular carcinoma by demonstrating hepatocyte-associated mRNA in the nuclear cell component of peripheral blood using nested reverse transcription-polymerase chain reaction because of the extremely small number of tumor cells in the circula
The serum apolipoprotein A (Apo A) and afetoprotein (AFP) were evaluated in histologically verified 30\* cases of alcoholic cirrhosis and 18 cases of hepatocellular carcinoma (HCC). The latter were also divided into subgroups depending on the presence or \*Abstracts are republished exactly as they w
For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either alpha-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular